Rezultati - Judith Hartleib

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    The effect of severe renal impairment on the pharmacokinetics, safety, and tolerability of balcinrenone

    The effect of severe renal impairment on the pharmacokinetics, safety, and tolerability of balcinrenone od Chandrali Bhattacharya, Hans Ericsson, Susanne Johansson, Joanna Parkinson, Simina M. Boca, Ye Yang, Maria Heijer, Greggory Housler, Maria Leonsson‐Zachrisson, Judith Hartleib‐Geschwindner, Patricia Ely Pizzato

    Izdano 2024
    Polni tekst
    Pré-impressão
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    Preclinical pharmacology of AZD9977: A novel mineralocorticoid receptor modulator separating organ protection from effects on electrolyte excretion

    Preclinical pharmacology of AZD9977: A novel mineralocorticoid receptor modulator separating organ protection from effects on electrolyte excretion od Krister Bamberg, Ulrika Johansson, K. A. P. Edman, Lena William‐Olsson, Susanna Myhre, Anders Gunnarsson, Stefan Geschwindner, Anna Aagaard, Anna Granqvist, Frédéric Jaisser, Yufeng Huang, Kenneth L. Granberg, Rasmus Jansson‐Löfmark, Judith Hartleib‐Geschwindner

    Izdano 2018
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    Antisense oligonucleotide treatment ameliorates IFN-γ–induced proteinuria in APOL1-transgenic mice

    Antisense oligonucleotide treatment ameliorates IFN-γ–induced proteinuria in APOL1-transgenic mice od Mariam Aghajan, Sheri Booten, Magnus Althage, Christopher Hart, Anette Ericsson, Ingela Maxvall, Joseph Ochaba, Angela Menschik-Lundin, Judith Hartleib, Steven Kuntz, Danielle Gattis, Christine Ahlström, Andrew T. Watt, Jeffery A. Engelhardt, Brett P. Monia, Maria Chiara Magnone, Shuling Guo

    Izdano 2019
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    Balcinrenone plus dapagliflozin in patients with heart failure and chronic kidney disease: Results from the phase 2b <scp>MIRACLE</scp> trial

    Balcinrenone plus dapagliflozin in patients with heart failure and chronic kidney disease: Results from the phase 2b <scp>MIRACLE</scp> trial od Carolyn S.P. Lam, Lars Køber, Koichiro Kuwahara, Lars H. Lund, Patrick B. Mark, Linda Mellbin, Morten Schou, Patricia Ely Pizzato, Anders Gabrielsen, Samvel B. Gasparyan, Alessandro Ghiretti, Judith Hartleib‐Geschwindner, Greggory Housler, Paolo Fanti, Maria Leonsson‐Zachrisson, John J.V. McMurray, Scott D. Solomon

    Izdano 2024
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: